The number of people suffering from eating
disorders worldwide is expected to increase significantly over the coming
decades, potentially reaching approximately 21.8 million by 2050. According to
a study published in the American medical journal JAMA Psychiatry,
approximately 18.1 million people worldwide were suffering from two eating
disorders in 2023: anorexia nervosa, characterized by severe food restriction,
and bulimia nervosa, which involves episodes of excessive eating followed by
vomiting or other attempts to prevent weight gain. This figure was
approximately 71 percent higher than in 1990.
The study estimates that if current trends
continue, the number of people affected by these two disorders could rise to
21.8 million by 2050. This projection could help healthcare authorities
estimate future treatment requirements and plan medical services accordingly. People
with anorexia nervosa typically severely restrict their food intake and
experience an intense fear of gaining weight. Meanwhile, those suffering from
bulimia nervosa repeatedly consume excessive amounts of food and then resort to
vomiting or other unhealthy methods to prevent weight gain. Both disorders can
have serious consequences for physical and mental health. The researchers examined
data from 204 countries and territories, drawing on multiple sources, including
the Global Burden of Disease study, surveys, published research papers and
mortality records.
According to the findings, approximately 14.2
million people were suffering from bulimia nervosa in 2023, while around 3.9
million had anorexia nervosa. Together, the two disorders accounted for
approximately 3.8 million years of healthy life lost. This measure includes
both the years lived with illness and the years lost due to premature death. The
study also identified differences in the age groups most affected by the two
disorders. Anorexia nervosa was found to be more common among adolescents aged
15 to 19, while bulimia nervosa was more prevalent among people aged 30 and
above. Women accounted for approximately 70 percent of those affected by both
disorders.
Regionally, the highest prevalence rates were
recorded in Australia, New Zealand and Western Europe. Meanwhile, East and
South Asia experienced significant increases in the prevalence of these
disorders since 1990. According to the researchers, differences in prevalence
across regions are important for healthcare planning. However, these variations
may also be influenced by the availability of data. In some countries, a lack
of surveys and specialized medical facilities makes it difficult to determine
the actual number of people affected, particularly those whose symptoms remain
undetected or who cannot access diagnosis and treatment.
The study emphasized that the projection of 21.8
million cases by 2050 is an estimate based on assumptions about future
population growth and existing disease trends. It also clarified that the
research covered only anorexia nervosa and bulimia nervosa. Therefore, the
findings do not represent the full scale of all eating disorders or the overall
future demand for treatment and healthcare services.